‘Glee’ trademark dispute continues as Fox granted appeal

Hollywood studio allowed to file motion for review on one ground; unusual Supreme Court review of earlier appeal

Trademark, UK, Europe

Sale of devices that link to protected content deemed ‘unlawful’

AG says hyperlinks to unlicensed copyright works is an infringement and a communication to a new public

Copyright, Licensing, Europe

Samsung v Apple: ‘years of turmoil’ to come for calculating damages

SCOTUS reverses and remands CAFC decision in $400m infringement case, but provides no guidance to the lower courts on how to devise damages test

Patent, Design, US & Canada

Pfizer fined £84m for ‘excessive’ drug pricing

Pharma manufacturer and distributor Flynn Pharma sanctioned with ‘record fine’ for abusing dominant market position over anti-epilepsy drug; generics welcome judgment

Patent, Licensing, UK

Life Tech litigation clashes with ‘America first’ trade policy

‘Chilling effects’ for US exports in SCOTUS case; may ‘ironically disadvantage’ suppliers during highly-charged debate on global trade

Patent, Licensing, UK, US & Canada

Courageous, optimistic, risky…

News the UK government was pushing ahead with the UPC was met with a mixture of surprise and relief. But the country’s own participation will require a political solution, says Tom Phillips

Patent, UK, Europe

Trump the reformer?

Despite a lack of pronouncements, President-elect Trump has offered clues as to how he might impact IP. Colette Reiner Mayer and Diek Van Nort examine the evidences

Patent, US & Canada

Wilful infringement: consequences and best practices

David Chun and Courtney Cox discuss implications for accused infringers following the US Supreme Court’s 2016 decision on enhanced damages


AstraZeneca, Apotex and patent utility

Supreme Court of Canada has heard important appeal regarding the ‘promise doctrine’. Jean-Charles Grégoire explores

Patent, US & Canada

The ‘suitcase’ effect

Carrie Johnson reviews the biggest UK design developments in 2016

Design, UK

UK patent litigation in 2016

Another busy year for UK patent litigation provided essential takeaways for disputes lawyers

Patent, Licensing, UK

Arrow declarations: an obvious weapon for generics?

The jurisdiction identified in Arrow has potentially game-changing implications for the future of competition in the pharma sector. Richard Roberts explores

Patent, Licensing, UK

Framing the virtual copyright challenge

With mass user adoption expected over the next few years, augmented and virtual reality may also herald mass copyright clearances, argues Sachin Premnath

Copyright, UK

ICANN…be independent

From the Trademark Clearinghouse to dispute resolution, Joanne Goodchild provides an overview of ICANN’s remit following its expired contract with the US government

Trademark, UK, US & Canada, Europe

How much detail should you provide in a patent infringement complaint?

Jason Murata and Ryan A Cook examine the fallout from the demise of Form 18

Patent, US & Canada

Camera shy

Can I use a trademark in a film? Sure, just respect the mark and avoid negative connotations, explains Lisa A Callif

Trademark, UK, US & Canada, Europe

When expert opinion is excluded

After the exclusion of a damages expert, is the patent holder still entitled to no less than a reasonable royalty? Jason F Hoffman from BakerHostetler investigates

Patent, Strategy, US & Canada